|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.25 TWD | -1.50% |
|
-2.42% | -1.69% |
AmCad BioMed Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 61.63 million compared to TWD 85.79 million a year ago. Net loss was TWD 53.49 million compared to TWD 25.54 million a year ago.
Basic loss per share from continuing operations was TWD 1.01 compared to TWD 0.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.69% | 43.23M | |
| -16.75% | 18.81B | |
| -41.26% | 2.93B | |
| +22.80% | 1.95B | |
| +7.25% | 1.79B | |
| +28.27% | 1.25B | |
| -6.82% | 1.07B | |
| -17.45% | 948M | |
| +0.15% | 770M | |
| -24.00% | 648M |
AMCAD BIOMED CORPORATION 